Prostate Liquescence Liquid
NDC Package 83027-0021-1
Package Information
Prostate Liquescence (sabal serrulata, taraxacum officinale, phytolacca decandra, thuja occidentalis, estradiol, progesterone, conium maculatum asterias rubens, euphorbium officinarum, triticum repens, calcarea fluorica, arsenicum album) liquids is adults 1 to 3 teaspoons one to three times daily. This formulation utilizes a liquid delivery system. Marketed by Nutritional Specialties, Inc., this product is identified by NDC 83027-0021.
Identification & Billing
Clinical Specifications
- ARSENIC TRIOXIDE 12 [hp_X]/mL
- ASTERIAS RUBENS 8 [hp_X]/mL
- CALCIUM FLUORIDE 12 [hp_X]/mL
- CONIUM MACULATUM FLOWERING TOP 7 [hp_X]/mL
- ELYMUS REPENS ROOT 10 [hp_X]/mL
- ESTRADIOL 4 [hp_X]/mL
- EUPHORBIA RESINIFERA RESIN 8 [hp_X]/mL
- PHYTOLACCA AMERICANA ROOT 4 [hp_X]/mL
- PROGESTERONE 4 [hp_X]/mL
- SAW PALMETTO 3 [hp_X]/mL
- TARAXACUM OFFICINALE 3 [hp_X]/mL
- THUJA OCCIDENTALIS LEAFY TWIG 4 [hp_X]/mL
Regulatory & Marketing
Hierarchy Structure
- 83027 - Nutritional Specialties, Inc.
- 83027-0021 - Prostate Liquescence
- 83027-0021-1 - 120 mL in 1 BOTTLE, GLASS
- 83027-0021 - Prostate Liquescence
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 83027-0021-1 identifies a specific commercial package of 120 ml in 1 bottle, glass of Prostate Liquescence, a human over the counter drug labeled by Nutritional Specialties, Inc.. This liquid is formulated for oral use and contains arsenic trioxide; asterias rubens; calcium fluoride; conium maculatum flowering top; elymus repens root; estradiol; euphorbia resinifera resin; phytolacca americana root; progesterone; saw palmetto; taraxacum officinale; thuja occidentalis leafy twig as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Nutritional Specialties, Inc. on February 24, 2023. The current certification is valid through December 31, 2026.
How is this Nutritional Specialties, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 83027002101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.